593P Pain efficacy with radium-223 (Ra-223) in the REASSURE global, prospective, observational study of men with metastatic castration-resistant prostate cancer (mCRPC)

Castration Resistant ◽

Radium 223

PD14-11 HEALTH-RELATED QUALITY OF LIFE (HRQL) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) TREATED WITH CABAZITAXEL (CBZ) IN A PROSPECTIVE OBSERVATIONAL STUDY (CAPRISTANA)

The Journal of Urology ◽

10.1016/j.juro.2018.02.797 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Angelika Pichler ◽

Gisoo Barnes ◽

Jana Katolicka ◽

Hana Korunkova ◽

Antoaneta Tomova ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Observational Study ◽

Health Related Quality ◽

Castration Resistant ◽

Related Quality ◽

Health Related

Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO)

BMC Cancer ◽

10.1186/s12885-019-5974-9 ◽

2019 ◽

Vol 19 (1) ◽

Author(s):

Javier Puente ◽

Aranzazu González-del-Alba ◽

Núria Sala-Gonzalez ◽

María José Méndez-Vidal ◽

Alvaro Pinto ◽

...

Keyword(s):

Prostate Cancer ◽

Observational Study ◽

Abiraterone Acetate ◽

Subsequent Treatment ◽

Efficacy And Safety ◽

First Line ◽

Cabazitaxel after Docetaxel in patients with metastatic, castration-resistant, prostate cancer (mCRPC): A prospective, observational study about toxicity profile and quality of life.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e16054 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e16054-e16054

Author(s):

Giovanni Mansueto ◽

Michele De Tursi ◽

Raffaele Ratta ◽

Maria Agnese Fabbri ◽

Silvia Quadrini ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Observational Study ◽

Toxicity Profile ◽

REASSURE observational study of radium-223 (Ra-223): First interim results by prior/concomitant treatment (Tx) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) enrolled in Europe

European Urology Supplements ◽

10.1016/s1569-9056(18)32277-2 ◽

2018 ◽

Vol 17 (2) ◽

pp. e1855-e1856 ◽

Cited By ~ 1

Author(s):

J. Logue ◽

M. Schostak ◽

S. Baldari ◽

D. Schrijvers ◽

J. Sandzén ◽

...

Keyword(s):

Prostate Cancer ◽

Observational Study ◽

Concomitant Treatment ◽

Castration Resistant ◽

Radium 223

The Prostate Cancer Registry: Analysis of Medical Resource Utilisation (Mru) in An International, Prospective, Observational Study of Men with Metastatic Castration-Resistant Prostate Cancer (Mcrpc)

Value in Health ◽

10.1016/j.jval.2015.09.1315 ◽

2015 ◽

Vol 18 (7) ◽

pp. A482

Author(s):

S Chowdhury ◽

A Birtle ◽

A Bjartell ◽

L Costa ◽

S Feyerabend ◽

...

Keyword(s):

Prostate Cancer ◽

Observational Study ◽

Cancer Registry ◽

Resource Utilisation ◽

Medical Resource ◽

Castration Resistant ◽

Registry Analysis

Health-related quality of life (HRQL) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with cabazitaxel (CBZ) in a prospective observational study (CAPRISTANA)

Annals of Oncology ◽

10.1093/annonc/mdx370.029 ◽

2017 ◽

Vol 28 ◽

pp. v281

Author(s):

A. Pichler ◽

G. Barnes ◽

J. Katolicka ◽

H. Korunkova ◽

A. Tomova ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Observational Study ◽

Health Related Quality ◽

Castration Resistant ◽

Related Quality ◽

Health Related

MP52-14 THE EFFECTIVENESS AND SAFETY OF CABAZITAXEL (CBZ) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) IN ROUTINE CLINICAL PRACTICE: RESULTS OF A PROSPECTIVE OBSERVATIONAL STUDY (CAPRISTANA)

The Journal of Urology ◽

10.1016/j.juro.2018.02.1665 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Joan Carles ◽

Jana Katolicka ◽

Hana Korunkova ◽

Antoaneta Tomova ◽

Marwan Ghosn ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Practice ◽

Observational Study ◽

Routine Clinical Practice ◽

594P Pain efficacy with radium-223 (Ra-223) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the PARABO observational study

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1107 ◽

2021 ◽

Vol 32 ◽

pp. S641

Author(s):

H. Palmedo ◽

H. Ahmadzadehfar ◽

S. Eschmann ◽

I. Selkinski ◽

F. Straube ◽

...

Keyword(s):

Prostate Cancer ◽

Observational Study ◽

Castration Resistant ◽

Radium 223

A European prospective observational study of enzalutamide (ENZA) in patients with metastatic castration-resistant prostate cancer (mCRPC): PREMISE

European Urology Open Science ◽

10.1016/s2666-1683(20)33170-0 ◽

2020 ◽

Vol 19 ◽

pp. e883-e884

Author(s):

H. Payne ◽

A. Robinson ◽

B. Rappe ◽

S. Hilman ◽

U. De Giorgi ◽

...

Keyword(s):

Prostate Cancer ◽

Observational Study ◽

Abstract 1413: Exploring the prognostic value of microRNAs and drug exposure in patients with metastatic castration resistant prostate cancer treated with abiraterone: a prospective observational study

10.1158/1538-7445.am2020-1413 ◽

2020 ◽

Author(s):

Emmy Boerrigter ◽

Guillemette E. Benoist ◽

Inge M. van Oort ◽

Gerald W. Verhaegh ◽

Onno van Hooij ◽

...

Keyword(s):

Prostate Cancer ◽

Observational Study ◽

Prognostic Value ◽

Drug Exposure ◽